ReviewEuropean journal of pediatrics2026
Sudden unexpected deaths in children: distinct entities.
Review in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sudden unexpected deaths in early life have historically been grouped under broad, inconsistent terminology, limiting epidemiologic precision and mechanistic understanding. Standardized investigation and surveillance now permit clearer differentiation among distinct entities. The goal of this project is to synthesize epidemiologic, forensic, and molecular evidence supporting classification of sudden unexpected postnatal collapse (SUPC), sudden unexpected infant death (SUID), and sudden unexpected death in childhood (SUDC) as distinct entities, and to examine whether shared biologic vulnerability underlies cases across age groups. A narrative review used population-based epidemiologic studies, national and international surveillance data, forensic pathology reports, and molecular autopsy investigations, emphasizing standardized definitions, age-stratified analyses, and comprehensive death-scene investigation. SUPC is rare, occurs almost exclusively within the first postnatal week, and is linked to early caregiving context during physiologic transition. SUID is more common (approximately 101 per 100,000 US live births in 2022), peaks at 1 to 4 months, and shows robust associations with modifiable sleep-environment factors. SUDC is rare, occurs predominantly after age 1, and lacks consistent environmental risk factors; data suggest contributions from autonomic instability or seizure susceptibility. Molecular autopsy studies in SUID and SUDC have identified variants in genes governing cardiac conduction, autonomic regulation, and neuronal excitability, suggesting shared intrinsic vulnerability in a subset, though cohorts remain small. Conclusions: SUPC, SUID, and SUDC are distinct entities warranting separate classification and prevention strategies. Emerging but limited molecular data support further investigation of cross-age biologic vulnerability. Accurate classification, standardized investigation, and molecular integration are needed to advance the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.